Integration of digital fluoroscopy with CT-based radiation therapy planning of lung tumors.

Radiation dose escalation may be a means to increase the local control rate of inoperable lung tumors. Treatment plans involve the creation of a uniform planning target volume (PTV) to ensure proper coverage despite patient breathing and setup error. This may lead to unnecessary radiation of normal tissue in shallow breathers or target underdosing for patients with excess internal motion. Therefore, the nature of tumor motion for each patient should be measured in 3D, something that cannot be done with CT alone. We have developed a method that acquires 2D real-time fluoroscopic images (loops) and coregisters them with 2D digitally reconstructed radiographs (DRR) formed from the CT scan. The limitations of CT to encompass motion can be overcome by merging the two modalities together. The accuracy of the coregistration method is tested with a stationary grid of radio-opaque markers at various spatial positions. The in-plane (at-depth) displacement between markers on the fluoroscopic image versus the DRR varies with position across the image due to slight misalignments between the x-ray source used in fluoroscopy and the virtual source used for the DRR relative to the test object. At clinically relevant positions, the maximum, measured in-plane displacement, is 1.1 mm. The method is applied to the thorax of an anthropomorphic phantom and a good fit is observed between the appearances of the bony anatomical structures on the coregistered image. Finally, a series of motion measurements are carried out on two oscillating cylindrical objects. The degree of motion as measured by fluoroscopy is accurate to within 1.0 mm, whereas the DRR is inconsistent in predicting motion. The coregistration of fluoroscopic loops with the DRR shows at what point within the oscillation the DRR fails to encompass motion. For any treatment site involving target motion, this real-time imaging is a useful asset in the planning stage.

[1]  Isaias D. Job,et al.  Characterization of a third-generation multimode sensor panel , 1999, Medical Imaging.

[2]  A R Cowen,et al.  Threshold contrast detail detectability measurement of the fluoroscopic image quality of a dynamic solid-state digital x-ray image detector. , 2001, Medical physics.

[3]  J. Ciezki,et al.  Fluoroscopic study of tumor motion due to breathing: facilitating precise radiation therapy for lung cancer patients. , 2001, Medical physics.

[4]  R. Jaszczak,et al.  Relating radiation-induced regional lung injury to changes in pulmonary function tests. , 2001, International journal of radiation oncology, biology, physics.

[5]  J C Rosenwald,et al.  Conformal radiotherapy (CRT) planning for lung cancer: analysis of intrathoracic organ motion during extreme phases of breathing. , 2001, International journal of radiation oncology, biology, physics.

[6]  S Senan,et al.  Multiple "slow" CT scans for incorporating lung tumor mobility in radiotherapy planning. , 2001, International journal of radiation oncology, biology, physics.

[7]  W. Stanford,et al.  Analysis of movement of intrathoracic neoplasms using ultrafast computerized tomography. , 1990, International journal of radiation oncology, biology, physics.

[8]  D. Joseph,et al.  A randomised phase III study of accelerated or standard fraction radiotherapy with or without concurrent carboplatin in inoperable non-small cell lung cancer: final report of an Australian multi-centre trial. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[9]  R Mackie,et al.  A new approach to dose escalation in non-small-cell lung cancer. , 2001, International journal of radiation oncology, biology, physics.

[10]  S. Korfee,et al.  Lung cancer: Combined modality therapy in NSCLC , 2000 .

[11]  James A. Purdy,et al.  3-D Conformal Radiotherapy for Lung Cancer , 1996 .

[12]  J. Purdy,et al.  Three-dimensional conformal radiotherapy in bronchogenic carcinoma: considerations for implementation. , 1994, Lung cancer.

[13]  R K Ten Haken,et al.  Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy: update of a phase I trial. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  Hyperfractionated radiation therapy and concurrent low-dose, daily carboplatin/etoposide with or without weekend carboplatin/etoposide chemotherapy in stage III non-small-cell lung cancer: a randomized trial. , 2001 .

[15]  A Harvey,et al.  Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial. CHART Steering committee. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[16]  M. Martel,et al.  Dose escalation for non-small cell lung cancer using conformal radiation therapy. , 1997, International journal of radiation oncology, biology, physics.

[17]  H Shirato,et al.  Impact of respiratory movement on the computed tomographic images of small lung tumors in three-dimensional (3D) radiotherapy. , 2000, International journal of radiation oncology, biology, physics.

[18]  H. Choy,et al.  Phase I trial of outpatient weekly docetaxel, carboplatin and concurrent thoracic radiation therapy for stage III unresectable non-small-cell lung cancer: a Vanderbilt cancer center affiliate network (VCCAN) trial. , 2001, Lung cancer.

[19]  M. Kris,et al.  Promising survival with three-dimensional conformal radiation therapy for non-small cell lung cancer. , 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[20]  K. Lam,et al.  Uncertainties in CT-based radiation therapy treatment planning associated with patient breathing. , 1996, International journal of radiation oncology, biology, physics.

[21]  B. Freidlin,et al.  Twenty-two years of phase III trials for patients with advanced non-small-cell lung cancer: sobering results. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  J. Doroshow,et al.  Twice-weekly paclitaxel and weekly carboplatin with concurrent thoracic radiation followed by carboplatin/paclitaxel consolidation for stage III non-small-cell lung cancer: a California Cancer Consortium phase II trial. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.